With the new patent in China, it looks like ONCS will be going for a global partner. It makes perfect sense that they acquire a patent and approval now while looking for a licensing or partnership deal.
Sentiment: Strong Buy
Of course--the company is much more attractive with the patent in hand! Won't be surprised if we see a strong bull run from this news.